Product Development

CMC Technical and GMP Training

In-depth training for the full product lifecycle

We design and deliver on-site CMC quality and regulatory compliance training. Clients learn how to plan and execute product development and manufacturing strategies, and how to integrate CMC activities with regulatory requirements. Alira Health CMC Team's experienced guidance supports quality and compliance throughout the product lifecycle.
We can help you:
  • Design and deliver on-site CMC quality and regulatory compliance training
  • Advise on planning and executing product development and manufacturing strategies and how to integrate CMC activities with regulatory requirements
  • Plan personnel training programs
  • Guidance on Pre-IND briefing package and CMC section of IND/IMPD/BLA

Why choose Alira Health?

The Alira Health team is dedicated to delivering in-depth support and training. Our subject matter experts are:

  • Industry leaders in cGMP manufacturing, experienced in the creation and implementation of training processes and documentation for organizational GMP readiness
  • Focused on delivering integrated strategies that achieve regulatory and compliance standards throughout your product life cycle

Related news

Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)
Research & Development
Publications May 27, 2021
Buffers – Navigating New Demands On Downstream Raw Materials
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing(...)
Research & Development
Publications April 26, 2021
Recombinant Human Polyclonal Antibodies to Treat Disease
Congratulations to Alira Health’s Steven Chamow, PhD, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their(...)
Research & Development
News March 15, 2021
Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (, a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)
Research & Development
Publications March 9, 2021
A Primer on Potency Assays for Release of Biologics
A key criterion in determining the quality of a biologic product is whether it has maintained its biological activity or “potency.”
Advanced Analytics Regulatory Research & Development
News November 20, 2020
Alira Health’s Ventures Portfolio Company, X-COR Therapeutics, Closes Initial $2.6M Funding Round
Alira Health congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.